CONTRIBUTION A L'ETUDE DE LA TRYPANOSOMIASE AU TCHAD: APPORT DE L'IMMUNOFLUORESCENCE INDIRECTELOUCQ CHRISTIAN.sd; FRA; PARIS: DACTYLO-SORBONNE; DA. S.D.; 83; 107-VI P.-PL.; 30 CM; BIBL. 6 P.; TH.: MED./PARIS 7/1979Thesis

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccinesIZURIETA, Hector S; ZUBER, Patrick; BLACK, Steve et al.Vaccine. 2013, Vol 31, Num 35, pp 3623-3627, issn 0264-410X, 5 p.Article

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunitiesBIRKETT, Ashley J; MOORTHY, Vasee S; LOUCQ, Christian et al.Vaccine. 2013, Vol 31, issn 0264-410X, B233-B243, SUP2Article

Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forwardNUNES, Julia K; WOODS, Colleen; BIRKETT, Ashley J et al.Vaccine. 2014, Vol 32, Num 43, pp 5531-5539, issn 0264-410X, 9 p.Article

Four year immunogenicity of the RTS,S/AS02_A malaria vaccine in Mozambican children during a phase IIb trialAIDE, Pedro; DOBANO, Carlota; HERREROS, Esperanza et al.Vaccine. 2011, Vol 29, Num 35, pp 6059-6067, issn 0264-410X, 9 p.Article

Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article